National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$34.50
add to cart

Rights & Permissions

topleft topright

Venture Funding and the NIH SBIR Program (2009)
National Research Council (NRC)

Citation Manager

. "Appendix C: NIH List of Firms Excluded on the Grounds of Venture Capital Ownership." Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press, 2009.

Please select a format:

BibTeX EndNote RefMan


Page
81
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Venture Funding and the NIH SBIR Program

Handylab Inc.

IDM Pharma, Inc.

Infigen, Inc.

Inotek Pharmaceuticals

Lincoln Technologies

Macrogenics, Inc.

MEMX

Metabolon, Inc.

MicroOptical Corporation

MicroOptical Engineering Corporation

Myomatrix Therapeutics

NanoMix, Inc.

NanoString Technologies, Inc.

Natus Medical (BioLogics)

Nephros Therapeutics, Inc.

Neurogenetics, Inc.

Norak Biosciences, Inc.

Northwest Medical Physics Equipment

Paratek Pharmaceuticals

Peptx, Inc.

Phenomix Corp.

PTC Therapeutics, Inc.

Saegis Pharmaceuticals Inc.

Sentrx Surgical/Carbylan Biosurgery

Sirtris Pharmaceuticals

Threshold Pharmaceuticals, Inc.

Transave, Inc.

Traxtal, Inc.

Trellis Bioscience

Tularik, Inc.

Vion Pharmaceuticals, Inc.

Virxsys Corp.

VisEn Medical, Inc.

Yasoo Health, Inc.

Page
81